Safety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular Edema

NCT02732951 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Macular Edema

Interventions

DRUG: BI 1026706
DRUG: Placebo

Sponsor

Boehringer Ingelheim